Inova Health’s Post

In patients with STEMI transferred for primary PCI, pretreatment with P2Y12 inhibitors significantly reduced the risk of 30-day major adverse cardiac events (MACE) without increasing bleeding risk, particularly when administered more than 80 minutes before PCI. This suggests that early administration of P2Y12 inhibitors can provide a superior net clinical benefit compared to in-cath lab administration. More info on the latest #ESCTVToday episode. https://bit.ly/3zGzZQY Sign up for reminders so you Never Miss a Beat https://bit.ly/3IQ1B7G #Cardiovascular #Cardiology

🌟 **New Article Alert!** 🌟 I’m excited to share my latest research publication: "A Perspective on a Two-stent Approach in Bifurcation Cases."** This comprehensive review addresses the challenges and solutions in treating bifurcation lesions, which are notably complex and represent a significant portion of percutaneous coronary interventions. One of the key aspects we explore is the impact of side branch (SB) length on treatment strategies for bifurcation lesions. Our research reveals: -The critical role of SB length in determining the necessity and success of a two-stent approach. -Data from pivotal trials like DK CRUSH V, demonstrating improved outcomes with specific stenting techniques for SBs over 2.5 mm in diameter and longer than 16 mm. Our goal is to provide a detailed roadmap for interventional cardiologists to enhance procedural success and patient outcomes. Don't miss out on this essential read for anyone involved in coronary interventions! https://lnkd.in/d9yw9Nxk #Cardiology #DefinitionII #Medina #DKCrush #InterventionalCardiology #BifurcationLesions

Pie Medical Imaging has successfully completed patient enrollment for #FASTIII, the largest non-inferiority trial investigating angiography-based vessel fractional flow reserve (#CAAS #vFFR) in coronary revascularization. This trial, involving 2228 patients, compares vFFR-guided strategies to traditional FFR-guided strategies to determine the functional significance of coronary artery narrowing. Led by Dr. Joost Daemen from Thoraxcenter at Erasmus University Medical Center, this milestone marks a significant step towards better understanding and utilizing vFFR in clinical practice. The study’s primary endpoint focuses on all-cause death, myocardial infarction, or revascularization one year post-randomization, with results expected by the end of 2025. Learn more about this milestone achievement and its impact on cardiac imaging ▶ https://bit.ly/4euKG8W #PieMedicalImaging #CardiacImaging #ClinicalTrials #Cardiology #MedicalResearch #HealthcareInnovation #SiemensHealthineers

💡Have you heard about the 2nd registry of the MLCTO Academy? HostiumCTO, a retrospective, multi-center registry for the evaluation of the clinical outcome following ostial RCA CTO procedures The prevalence of ostial CTO lesions of the RCA is the most prevalent and constitutes an increased challenge during PCI owing to the difficult engagement of the lesion as well as the use of the retrograde approach. The long-term clinical and angiographic outcomes of such lesions need to be refined in a large international registry. ✅Primary Endpoint: To assess the long-term (>6 months) clinical follow-up of patients who underwent a CTO procedure of an ostial RCA. ✅Secondary Endpoint: 1- Angiographic patency of any stent implanted during the procedure; Rate of complications (composite of cardiac death, myocardial infarction, major bleeding, and cardiac tamponade) of the index procedure. Discover more and participate! https://swll.to/2tFTupF #HostiumCTO #MLCTOAcademy #cardiology #research #CTO #RCA

🎙️NEW #AHA23 #LBCT Discussion 💫Dr Mandeep Mehra, MD, MSc, FRCP (London) joins Dr Harriette Van Spall to discuss the ARIES HM3 clinical trial. 📽️Watch in full here👉 https://ow.ly/n1ih50Q6GQ3 📊Omission of aspirin from an antithrombotic regimen including a VKA in advanced heart failure patients with LVAD was associated with a reduction in bleeding events and a 47% decrease in the number of hospitalisation days without an increased risk of thromboembolic events. #Cardiology #ClinicalTrial #CardioEd

Atrial Fibrillation, or AFib, is the most commonly diagnosed arrhythmia, affecting millions of people worldwide. It is often misdiagnosed or not treated appropriately. Today, GE HealthCare announced the launch of our latest cardiology solution: CardioVisio for Atrial Fibrillation, a digital tool designed to help tell the story of the heart. We are excited that this innovative solution is now available to our US customers. CardioVisio for AFib assists the clinician in visualizing longitudinal data relevant for disease progression from multiple data sources, saving time and aiding clinical decision making by offering guideline-directed therapy recommendations. Each automated step includes explainability and traceability, allowing the healthcare provider to audit and edit the process and output with the goal of better meeting the needs of each unique AFib patient. Read more here: https://lnkd.in/eDnb-ZER And if you are at the European Society of Cardiology (ESC) Congress this week in Amsterdam, please come see us to learn more. #GEHealthCare #Cardiology #ESC2023 #ESCCongress #MedTech

🌟 Saturday morning, handled a case of a 99-year-old patient with significant chest pain and notable ECG changes. Our coronary angiography revealed a severely calcified left main bifurcation, Medina classification 1.1.1. We performed an IVUS-guided PCI using the culotte technique, leading to a satisfactory result. The patient is now stable monitored in the CCU. The day's not over, and I'm braced for more challenges ahead. #Cardiology #HeartHealth #IVUS #Leftmainbifurcation #interventionalcardiology

🎤 Dive into Dr. Ahmed Dakshi's insights on his poster “Imprecision and clinical performance of a whole blood high-sensitivity #pointofcare #troponin I: the first prospective real-time study in suspected acute #coronary syndrome” and the performance of the QuidelOrtho TriageTrue® High Sensitivity Troponin I Test. Watch the video now: https://lnkd.in/dHqyK3cE   #Thetimeisnow for POC hs-cTn to enhance your #emergencydepartment! 🏥   #PointOfCareTesting #emergencyrooms #NSTEMI #cardiology #ACS #emergencymedicine #chestpain #ECG #EKG #myocardial #infarction

Dr Joost Daemen and Prof Dagmara Hering present 'A New Momentum for Renal Denervation: 2023 ESH Guidelines', an informative broadcast exploring recent ESC guidelines for Renal Denervation (RDN). Register free ➡️ https://ow.ly/qXHg50Q7NtB 🗓️ 23 November ⏰ 15:30 GMT | 16:30 CET ✅Learn about the 2023 ESH guidelines about Renal Denervation ✅Deep dive into class of recommendation and level of evidence ✅Review Ultrasound RDN clinical evidence - Now FDA approved ✅Understand recommended patient pathways and hear case discussions #RDN #Cardiology #MedEd